Company Monitoring Page for Novo-Nordisk

latest headlines for company on cafepharma

Humira back on top of TV spending list for October, ahead of Lyrica and Victoza
Fierce Pharma
Mon, 11/6/17 - 10:12 am
Tags:
Humira, Lyrica, Victoza, AbbVie, Pfizer, Novo Nordisk, television ads, DTC ads
Diabetes industry keeps deteriorating: Sanofi and Novo announce declining sales (Q3 2017)
GoinPharma
Sat, 11/4/17 - 08:42 am
Tags:
Sanofi, Novo Nordisk, diabetes
Novo Nordisk shares slip on cautious guidance, insulin pricing concerns
Drug Delivery Business News
Wed, 11/1/17 - 10:02 am
Tags:
Novo Nordisk, earnings, diabetes, insulin, drug pricing
What to expect from the rest of pharma's earnings
BioPharma Dive
Mon, 10/30/17 - 09:52 am
Tags:
earnings, Pfizer, Allergan, Novo Nordisk, Sanofi, AstraZeneca
With FDA panel backing, Novo Nordisk prepares for semaglutide's potential launch
Fierce Biotech
Thu, 10/19/17 - 12:00 pm
Tags:
FDA, Novo Nordisk, semaglutide, diabetes
Novo's experimental diabetes drug likely to compete with Trulicity
Medical Marketing and Media
Tue, 10/17/17 - 08:29 pm
Tags:
Novo Nordisk, diabetes, Trulicity, semaglutide
FDA gives Novo Nordisk top grades for its diabetes drug semaglutide, but retinopathy remains key
Endpoints
Mon, 10/16/17 - 09:42 am
Tags:
FDA, Novo Nordisk, diabetes, semaglutide, diabetic retinopathy
Novo Nordisk wins FDA nod for fast-acting mealtime insulin
Drug Delivery Business News
Sat, 09/30/17 - 10:20 am
Tags:
Novo Nordisk, FDA, diabetes, insulin, Fiasp
Severe hypoglycemia multiplies death risk up to fourfold in diabetes, Novo Nordisk finds
Fierce Pharma
Fri, 09/15/17 - 11:19 am
Tags:
Novo Nordisk, diabetes, hypoglycemia, EASD
EASD: Novo Nordisk's combo Xultophy beat rivals at cutting LDL, blood pressure
Fierce Pharma
Wed, 09/13/17 - 10:57 am
Tags:
Novo Nordisk, Xultophy, LDL cholesterol, EASD
Nordisk settles DOJ’s Victoza marketing suit for $59m
Drug Delivery Business News
Wed, 09/6/17 - 10:40 am
Tags:
Novo Nordisk, DOJ, Victoza, drug marketing
Novo’s Victoza, new indication to reduce CV risk
GoInPharma
Sun, 08/27/17 - 06:24 pm
Tags:
Novo Nordisk, Victoza, diabetes, cardiovascular disease
FDA clears Novo Nordisk's diabetes drug to reduce cardiovascular risk
Yahoo/Reuters
Sat, 08/26/17 - 11:56 am
Tags:
Novo Nordisk, FDA, diabetes, Victoza
Diabetes drugs must prove their value to payers, analysts say
Medical Marketing and Media
Tue, 08/22/17 - 06:48 pm
Tags:
diabetes, payers, Novo Nordisk, semaglutide, Eli Lilly, Trulicity
The best drug is not always a guarantee for the best financial results
GoInPharma
Wed, 08/16/17 - 09:37 pm
Tags:
Novo Nordisk, Tresiba, diabetes, insulin
Novo focuses on new obesity therapy Semaglutide
GoInPharma
Tue, 08/15/17 - 09:31 am
Tags:
Novo Nordisk, obesity, semaglutide
The 2017 report card so far: Big Biotech largely trading up as pharma posts mixed results
Fierce Pharma
Thu, 08/10/17 - 06:58 pm
Tags:
pharma stocks, Merck, Pfizer, AbbVie, Eli Lilly, Bristol-Myers Squibb, GSK, Roche, Sanofi, Bayer, Novo Nordisk, Celgene, Biogen, AstraZeneca
Can Novo’s blockbuster push on obesity drug semaglutide succeed where others failed?
Endpoints
Thu, 08/10/17 - 11:36 am
Tags:
Novo Nordisk, semaglutide, obesity
Novo Nordisk leans on Victoza as competition increases
BioPharma Dive
Wed, 08/9/17 - 03:09 pm
Tags:
Novo Nordisk, Victoza
Novo Nordisk profit flat; upbeat on sales outlook
Marketwatch
Wed, 08/9/17 - 11:15 am
Tags:
Novo Nordisk, earnings

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.